Cell therapy · Exosomes
Exosome therapy:
the stem cell’s message.
MSC-derived exosomes are nano-vesicles that carry much of a stem cell’s regenerative signalling — without the living cell. A cell-free option for inflammatory and degenerative conditions, delivered as registered clinical research at China’s Class A hospitals. Strong rationale, emerging evidence, graded honestly.
30–150nm
Vesicle size
Nano-scale, tissue-penetrating
Cell biology
Cell-free
No living cells
Lower immunogenicity, no cell growth risk
Mechanism
Emerging
Evidence grade
Strong rationale, trials maturing
Literature, 2024
$6–15k
Protocol all-in
Lower than living-cell therapy
Industry data
GMP-style
Production
Registered research, release-tested
NHC framework
Class A
All partner facilities
NMPA-licensed cellular labs
NHC / NMPA
What they are
Nano-messengers,
cell-free repair.
Exosomes are tiny vesicles — 30 to 150 nanometres — that cells release to talk to one another. Mesenchymal stem cells pack theirs with proteins, microRNA and lipids that drive tissue repair and immune regulation. Exosome therapy delivers those messengers directly, capturing much of the stem cell’s signalling effect without infusing a living cell.
Being cell-free brings real advantages: lower immunogenicity, no risk of unwanted cell growth, easier standardisation and storage, and good tissue penetration at nano-scale. The honest trade-off is that exosomes don’t engraft or self-renew — their benefit relies entirely on their cargo, so they complement rather than replace MSC therapy.
The field is genuinely promising but still maturing — production standards and large trials are catching up to the biology. In China, legitimate exosome treatment is registered clinical research at licensed Class A hospitals. We’re explicit that most indications are emerging, and we steer clear of the unlicensed cosmetic “exosome” market entirely.
Applications
Where exosomes are studied.
Osteoarthritis & cartilage
MSC exosomes are studied for cartilage repair and joint inflammation — a cell-free adjunct or alternative to intra-articular MSC. Early signals positive; large trials pending.
Wound & skin healing
Exosomes carry pro-repair signalling that supports tissue regeneration in chronic wounds and skin — an active research area, including dermatologic uses.
Immune modulation
By relaying MSC immunoregulatory signals, exosomes are studied for inflammatory and immune-related conditions — without infusing living cells.
Drug delivery
Their nano-scale and natural targeting make exosomes a promising vehicle to carry therapeutic cargo to specific tissues — largely pre-clinical / research-stage.
Regenerative medicine
Broad interest in tissue repair across organ systems via exosome signalling; mechanism well-motivated, clinical validation still developing.
Cosmetic 'exosome' claims
Unlicensed cosmetic 'exosome' products are widespread and unverified. We don't endorse these — only registered, release-tested products at licensed facilities.
Exosome therapy is an emerging biologic. The mechanistic rationale is strong and early clinical results are encouraging, but large high-quality randomised trials are still limited. In China it is delivered as registered clinical research at licensed Class A hospitals — not as an NMPA-approved drug, and not the same as unlicensed cosmetic “exosome” products.
Quality control
How a real product is verified.
Identification & characterisation
Electron microscopy for morphology, nanoparticle analysis for size distribution, and protein/nucleic-acid markers to confirm the product genuinely is exosomes — establishing specificity.
Biological activity
Functional assays verify the exosomes' regulatory and reparative effects (e.g. on immune cells), confirming potency rather than just presence.
Purity & endogenous substances
Testing for residual culture proteins, nucleic acids and other process impurities to ensure the product meets purity standards.
Pathogen & safety testing
Screening for pathogen contamination and immunogenicity assessment, with stability data across temperature and storage conditions for clinical reliability.
Production
From MSC culture
to release-tested vesicles.
MSC culture
Mesenchymal stem cells are cultured under controlled conditions — media, temperature, humidity and density all tuned, since they directly affect cell health and exosome yield.
Exosome separation
Exosomes are isolated from culture supernatant using techniques such as ultracentrifugation, with care taken to preserve vesicle integrity and purity.
Washing & purification
Vesicles are washed and purified to remove residual media and process impurities, raising product purity.
Storage & cryopreservation
Purified exosomes are stored (often cryopreserved) to maintain activity and stability until clinical use.
Release testing & use
Batches pass characterisation, activity, purity and safety testing before being administered under a registered protocol, with monitoring and follow-up.
FAQ
Exosome therapy, answered.
- What are exosomes?
- Exosomes are nano-sized extracellular vesicles (roughly 30–150 nanometres) released by cells — including mesenchymal stem cells (MSC). They carry a cargo of bioactive molecules: proteins, nucleic acids (mRNA, microRNA) and lipids. Through this cargo they relay signals between cells and play important roles in tissue repair, immune regulation and maintaining tissue balance. MSC exosomes are essentially the 'messengers' that carry much of the stem cell's regenerative signalling — without the cell itself.
- How is exosome therapy different from stem cell therapy?
- Exosome therapy is cell-free. Instead of infusing living stem cells, it delivers the vesicles MSC secrete. Potential advantages: no living cells means lower immunogenicity and no risk of unwanted cell growth; products can be more standardised and easier to store; nano-scale vesicles distribute well in tissue. The trade-off: exosomes don't engraft or self-renew, so effects rely on their signalling cargo. They're best seen as a related but distinct option alongside MSC therapy, not a replacement.
- What does exosome therapy treat, and how good is the evidence?
- Exosomes are studied mainly for inflammatory and degenerative conditions — osteoarthritis and cartilage repair, wound and skin healing, and immune modulation, with broader regenerative and drug-delivery research ongoing. Honest grading: the biological rationale is strong and early clinical results are promising, but high-quality, large randomised trials are still limited. We classify most exosome indications as emerging, delivered through registered clinical research, and we say so plainly.
- Is exosome therapy regulated in China?
- Exosomes are an emerging biologic, and standards for production and quality control are still maturing globally. In China, legitimate exosome treatment is delivered as registered clinical research at qualified Class A hospitals using products made under controlled, GMP-style processes with defined release testing. Be cautious of cosmetic clinics or unlicensed providers marketing 'exosome' products outside this framework — quality and safety there are not assured. Panda Touring Care only uses licensed facilities.
- How are exosomes produced and quality-controlled?
- Production runs from MSC culture (cell selection, media, temperature, humidity and density all affect yield), through exosome separation (e.g. ultracentrifugation), washing and purification to remove residual culture material, and finally storage/cryopreservation to preserve activity. Quality control covers identification and characterisation (electron microscopy, nanoparticle size analysis, protein and nucleic-acid markers), biological activity, purity, and endogenous-substance and pathogen testing — to ensure the product is specific, potent and safe.
- How much does exosome therapy cost in China?
- All-in exosome protocols typically run $6,000–$15,000 — generally lower than living-cell therapies because there's no harvest or cell-expansion-and-infusion logistics for the patient. Cost depends on the indication, number of administrations and product source. Request an itemized quote, and be wary of very cheap 'exosome' offerings, which are a red flag for unlicensed products.
- Can foreigners get exosome therapy in China?
- Yes — through international departments at Class A hospitals running registered exosome research protocols. Panda Touring Care reviews whether the evidence supports exosome therapy for your case, arranges the M-visa and on-site treatment, and follows up. Because much of the field is still emerging, we're selective about which cases we'll route.
Continue exploring
Stem Cell Therapy
The living-cell MSC pillar — exosomes' parent therapy.
Read on stem cellsImmune Cell Therapy
NK, CIK, DC-CIK and CAPRI — the immune side of cell therapy.
Read on immune cellsCell Banking
Store the MSC that exosomes are derived from.
Read on bankingDermatology in China
Where skin-repair and aesthetic regenerative research overlaps.
See dermatologyClinical Trials in China
How registered research access works for emerging biologics.
See trialsCell Therapy Hub
Pillar overview across every cell category in China.
Back to hubIs exosome therapy
right for your case?
Submit your records and a senior physician will tell you honestly whether the evidence supports exosome therapy for your condition — and which licensed Class A protocol applies. No cosmetic-clinic hype.